CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 27,188	$ 161,780
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(1,043)	(9,977)
Depreciation and amortization	4,372	4,528
Write down of other real estate, net of gain on sale	529	(7,989)
Amortization of other intangible assets	3,886	5,994
Net amortization of investment securities	6,111	10,766
Share-based compensation	2,100	3,168
Net gain on investment securities	(240)
Net gain on sales of residential loans	(4,151)	(8,492)
Proceeds from sales of loans held for sale	279,641	545,199
Originations of loans held for sale	(268,472)	(510,861)
Equity in earnings of unconsolidated subsidiaries	(422)	(733)
Increase in cash surrender value of bank-owned life insurance	(2,402)	(1,492)
Deferred income taxes	14,701	(115,683)
Premium paid on repurchases of preferred stock of subsidiaries		1,895
Net change in other assets and liabilities	702	(8,425)
Net cash provided by operating activities	62,500	69,678
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	104,784	387,409
Proceeds from sales of investment securities available for sale	162,470
Purchases of investment securities available for sale	(18,993)	(501,502)
Proceeds from maturities of and calls on investment securities held to maturity	12,046	9,980
Purchases of investment securities held to maturity	(2,443)	(4,595)
Net loan originations	(183,197)	(258,612)
Purchase of loan portfolio	(62,648)	(37,104)
Proceeds from sales of loans originated for investment		10,679
Proceeds from sale of other real estate	2,790	16,375
Proceeds from bank-owned life insurance	481
Purchases of premises and equipment	(4,425)	(3,920)
Distributions from unconsolidated subsidiaries	470	553
Contributions to unconsolidated subsidiaries	466	(9,050)
Proceeds from redemption of FHLB stock	1,736	1,302
Net cash provided by (used in) investing activities	13,537	(388,485)
Cash flows from financing activities:
Net increase in deposits	111,923	225,492
Repayments of long-term debt	(14)	(13)
Net increase (decrease) in short-term borrowings	(8,015)	28,000
Cash dividends paid on common stock	(9,841)	(3,367)
Repurchases of common stock and other related costs	(129,391)
Repurchases of preferred stock of subsidiaries		(11,781)
Net proceeds from issuance of common stock and stock option exercises	74
Net cash provided by (used in) financing activities	(35,264)	238,331
Net increase (decrease) in cash and cash equivalents	40,773	(80,476)
Cash and cash equivalents at beginning of period	49,348	177,375
Cash and cash equivalents at end of period	90,121	96,899
Cash paid during the period for:
Interest	4,796	17,436
Income taxes		5
Cash received during the period for:
Income taxes	79
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	11	39
Net reclassification of loans to other real estate	1,752	3,461
Net transfer of investment securities available for sale to held to maturity		$ 101,669

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.